{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/64764-123#drug","name":"OSENI","alternateName":"alogliptin and pioglitazone","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"64764-123"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA022426"},{"@type":"PropertyValue","propertyID":"UNII","value":"EEN99869SC|JQT35NPK6C"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"4c619ed9-fe3e-4158-9938-80c6c3493d55"}],"activeIngredient":"ALOGLIPTIN BENZOATE, PIOGLITAZONE HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"Takeda Pharmaceuticals America, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA022426","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c619ed9-fe3e-4158-9938-80c6c3493d55","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-123"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T01:51:23.220Z"}}